# EDGAR Filing Document

**Accession Number:** 0001209466
**File Stem:** 0001752724-25-161209
**Filing Date:** 2025-6
**Character Count:** 15317
**Document Hash:** 164902bbc8a1861a6cf695f6bb58c03f
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001752724-25-161209.hdr.sgml**: 20250627

**ACCESSION NUMBER**: 0001752724-25-161209

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250430

**FILED AS OF DATE**: 20250627

**DATE AS OF CHANGE**: 20250627

**PERIOD START**: 20250430

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INVESCO EXCHANGE-TRADED FUND TRUST
- **CENTRAL INDEX KEY:** 0001209466

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 0430

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-21265
- **FILM NUMBER:** 251082957

**BUSINESS ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515
- **BUSINESS PHONE:** 800-983-0903

**MAIL ADDRESS:**
- **STREET 1:** 3500 LACEY ROAD
- **STREET 2:** SUITE 700
- **CITY:** DOWNERS GROVE
- **STATE:** IL
- **ZIP:** 60515

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POWERSHARES EXCHANGE TRADED FUND TRUST
- **DATE OF NAME CHANGE:** 20021210

## Series and Classes Contracts Data

### Invesco Biotechnology & Genome ETF (Series ID: S000003026)

| Class ID   | Class Name                         | Ticker Symbol   |
|:---|:---|:---|
| C000008293 | Invesco Biotechnology & Genome ETF | PBE             |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Invesco Exchange-Traded Fund Trust

- **b. Investment Company Act file number:** 811-21265

- **c. CIK number of Registrant:** 0001209466

- **d. LEI of Registrant:** QPT4TMG79RF3UWNU0R52

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3500 Lacey Road

  - **City:** Downers Grove

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60515

  - **Telephone number:** 800-983-0903

**Item A.2. Information about the Series.**

- **a. Name of Series:** Invesco Biotechnology & Genome ETF

- **b. EDGAR series identifier (if any):** S000003026

- **c. LEI of Series:** 549300TC80GXFQLM7W73

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2025-04-30

- **b. Date as of which information is reported:** 2025-04-30

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $244175750.05

**Total Liabilities:** $22891398.24

**Net Assets:** $221284351.81

**Cash Not Reported:** $5728.01

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000008293 | -3.73%               | -4.80%               | -1.86%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $169747.74               | $-9735226.42                               |
| Month 2  | $2073875.14              | $-13714358.14                              |
| Month 3  | $504339.18               | $-4834440.18                               |

### Schedule of Portfolio Investments

| Name                                  | Title                                                      | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| Qiagen N.V.                           | Qiagen N.V.                                                | CUSIP: N72482206<br>LEI: 54930036WK3GMCN17Z57 | Long             | EC               | CORP              | NL        |    162590 | NS      | $6950728.28   | 3.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Collegium Pharmaceutical, Inc.        | Collegium Pharmaceutical, Inc.                             | CUSIP: 19459J104<br>LEI: 54930049FXZMTLW8D496 | Long             | EC               | CORP              | US        |    224177 | NS      | $6051658.12   | 2.73%             |  |  |  | No            |                  1 | On Loan: —       |
| Dynavax Technologies Corp.            | Dynavax Technologies Corp.                                 | CUSIP: 268158201<br>LEI: 549300T5URIXWDILX594 | Long             | EC               | CORP              | US        |    481349 | NS      | $5655850.75   | 2.56%             |  |  |  | No            |                  1 | On Loan: —       |
| Neurocrine Biosciences, Inc.          | Neurocrine Biosciences, Inc.                               | CUSIP: 64125C109<br>LEI: 549300FECER0XBN49756 | Long             | EC               | CORP              | US        |    102195 | NS      | $11005379.55  | 4.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Acadia Pharmaceuticals Inc.           | Acadia Pharmaceuticals Inc.                                | CUSIP: 004225108<br>LEI: 529900O3044NO0PEA039 | Long             | EC               | CORP              | US        |    339519 | NS      | $4956977.40   | 2.24%             |  |  |  | No            |                  1 | On Loan: —       |
| BioMarin Pharmaceutical Inc.          | BioMarin Pharmaceutical Inc.                               | CUSIP: 09061G101<br>LEI: NSLL8ITTRR0J5HEMR848 | Long             | EC               | CORP              | US        |     90700 | NS      | $5776683.00   | 2.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Blueprint Medicines Corp.             | Blueprint Medicines Corp.                                  | CUSIP: 09627Y109<br>LEI: 5299004CC60O9T5HVM83 | Long             | EC               | CORP              | US        |     70799 | NS      | $6336510.50   | 2.86%             |  |  |  | No            |                  1 | On Loan: —       |
| Regeneron Pharmaceuticals, Inc.       | Regeneron Pharmaceuticals, Inc.                            | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |     16373 | NS      | $9803497.48   | 4.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Xencor, Inc.                          | Xencor, Inc.                                               | CUSIP: 98401F105<br>LEI: 549300V5IF65437JKG30 | Long             | EC               | CORP              | US        |    446673 | NS      | $4922336.46   | 2.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences, Inc.                 | Gilead Sciences, Inc.                                      | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |    106203 | NS      | $11314867.62  | 5.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Royalty Pharma PLC                    | Royalty Pharma PLC, Class A                                | CUSIP: G7709Q104<br>LEI: 549300FGFN7VOK8BZR03 | Long             | EC               | CORP              | GB        |    191591 | NS      | $6288016.62   | 2.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Incyte Corp.                          | Incyte Corp.                                               | CUSIP: 45337C102<br>LEI: 549300Z4WN6JVZ3T4680 | Long             | EC               | CORP              | US        |     86742 | NS      | $5435253.72   | 2.46%             |  |  |  | No            |                  1 | On Loan: No      |
| United Therapeutics Corp.             | United Therapeutics Corp.                                  | CUSIP: 91307C102<br>LEI: 5299005C4HZL4UWROC14 | Long             | EC               | CORP              | US        |     33135 | NS      | $10042887.15  | 4.54%             |  |  |  | No            |                  1 | On Loan: No      |
| Exelixis, Inc.                        | Exelixis, Inc.                                             | CUSIP: 30161Q104<br>LEI: 254900PJQB59O2O95R37 | Long             | EC               | CORP              | US        |    174838 | NS      | $6844907.70   | 3.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc.                           | Biogen Inc.                                                | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |     82559 | NS      | $9996243.72   | 4.52%             |  |  |  | No            |                  1 | On Loan: No      |
| Halozyme Therapeutics, Inc.           | Halozyme Therapeutics, Inc.                                | CUSIP: 40637H109<br>LEI: 529900242I3SV9AGM753 | Long             | EC               | CORP              | US        |    111408 | NS      | $6842679.36   | 3.09%             |  |  |  | No            |                  1 | On Loan: No      |
| Natera, Inc.                          | Natera, Inc.                                               | CUSIP: 632307104<br>LEI: N/A                  | Long             | EC               | CORP              | US        |     75925 | NS      | $11459360.25  | 5.18%             |  |  |  | No            |                  1 | On Loan: No      |
| CareDx, Inc.                          | CareDx, Inc.                                               | CUSIP: 14167L103<br>LEI: 549300NQOFKL9NON0U06 | Long             | EC               | CORP              | US        |    308964 | NS      | $5215312.32   | 2.36%             |  |  |  | No            |                  1 | On Loan: —       |
| Veracyte, Inc.                        | Veracyte, Inc.                                             | CUSIP: 92337F107<br>LEI: 529900ESWZRHXOW27Z37 | Long             | EC               | CORP              | US        |    192906 | NS      | $5883633.00   | 2.66%             |  |  |  | No            |                  1 | On Loan: —       |
| Bio-Techne Corp.                      | Bio-Techne Corp.                                           | CUSIP: 09073M104<br>LEI: 54930073RLKQ51TILZ35 | Long             | EC               | CORP              | US        |    100507 | NS      | $5060527.45   | 2.29%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Private Prime Fund            | Invesco Private Prime Fund                                 | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |  16313117 | NS      | $16313116.97  | 7.37%             |  |  |  | No            |                  2 | On Loan: No      |
| PTC Therapeutics, Inc.                | PTC Therapeutics, Inc.                                     | CUSIP: 69366J200<br>LEI: 549300UJLWOIWFDGB318 | Long             | EC               | CORP              | US        |    128294 | NS      | $6394172.96   | 2.89%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc.                            | Amgen Inc.                                                 | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |     37524 | NS      | $10916482.08  | 4.93%             |  |  |  | No            |                  1 | On Loan: No      |
| Exact Sciences Corp.                  | Exact Sciences Corp.                                       | CUSIP: 30063P105<br>LEI: 549300VM3X1FYD4N9Z14 | Long             | EC               | CORP              | US        |    128620 | NS      | $5870216.80   | 2.65%             |  |  |  | No            |                  1 | On Loan: —       |
| Myriad Genetics, Inc.                 | Myriad Genetics, Inc.                                      | CUSIP: 62855J104<br>LEI: 52990044IHUOUMETT163 | Long             | EC               | CORP              | US        |    549717 | NS      | $4073402.97   | 1.84%             |  |  |  | No            |                  1 | On Loan: No      |
| Catalyst Pharmaceuticals, Inc.        | Catalyst Pharmaceuticals, Inc.                             | CUSIP: 14888U101<br>LEI: 5299004O0R5XXLA5H544 | Long             | EC               | CORP              | US        |    310607 | NS      | $7544644.03   | 3.41%             |  |  |  | No            |                  1 | On Loan: No      |
| Illumina, Inc.                        | Illumina, Inc.                                             | CUSIP: 452327109<br>LEI: SQ95QG8SR5Q56LSNF682 | Long             | EC               | CORP              | US        |    123695 | NS      | $9598732.00   | 4.34%             |  |  |  | No            |                  1 | On Loan: No      |
| MannKind Corp.                        | MannKind Corp.                                             | CUSIP: 56400P706<br>LEI: 213800GFBCNY1ZFST722 | Long             | EC               | CORP              | US        |   1142366 | NS      | $5757524.64   | 2.60%             |  |  |  | No            |                  1 | On Loan: —       |
| BioCryst Pharmaceuticals, Inc.        | BioCryst Pharmaceuticals, Inc.                             | CUSIP: 09058V103<br>LEI: 549300Z0INP1Z5NP6J59 | Long             | EC               | CORP              | US        |    779510 | NS      | $6898663.50   | 3.12%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Government & Agency Portfolio | Invesco Government & Agency Portfolio, Institutional Class | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    138392 | NS      | $138392.40    | 0.06%             |  |  |  | No            |                  1 | On Loan: No      |
| TG Therapeutics, Inc.                 | TG Therapeutics, Inc.                                      | CUSIP: 88322Q108<br>LEI: 529900X21UKABN9NJ529 | Long             | EC               | CORP              | US        |    221180 | NS      | $10065901.80  | 4.55%             |  |  |  | No            |                  1 | On Loan: —       |
| Invesco Private Government Fund       | Invesco Private Government Fund                            | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | PF                | US        |   6312059 | NS      | $6312059.19   | 2.85%             |  |  |  | No            |                  2 | On Loan: No      |
| Protagonist Therapeutics, Inc.        | Protagonist Therapeutics, Inc.                             | CUSIP: 74366E102<br>LEI: N/A                  | Long             | EC               | CORP              | US        |    184113 | NS      | $8436057.66   | 3.81%             |  |  |  | No            |                  1 | On Loan: —       |

### Signature

**Date Signed:** 2025-05-30

**Name of Applicant:** Invesco Exchange-Traded Fund Trust

**Signature:** Adrien Deberghes

**Name of Signer:** Adrien Deberghes

**Title:** Vice President